Evidence map›Paper›PMID 30005569›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2018

Hydrolytically Labile Linkers Regulate Release and Activity of Human Bone Morphogenetic Protein-6.

Jordi Cabanas-Danés, Ellie Landman, Jurriaan Huskens, Marcel Karperien, Pascal Jonkheijm

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Programmable Paracrine-Mimetic Microneedle System for Temporal Regulation of Cardiac Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Immobilization of Growth Factors for Cell Therapy Manufacturing.Frontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jordi Cabanas-DanésBioinspired Molecular Engineering Laboratory, TechMed Centre , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.
Ellie LandmanDevelopmental BioEngineering Group, TechMed Centre , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.
Jurriaan HuskensMolecular Nanofabrication Group, MESA+ Institute for Nanotechnology , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.ORCID 0000-0002-4596-9179
Marcel KarperienDevelopmental BioEngineering Group, TechMed Centre , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.
Pascal JonkheijmBioinspired Molecular Engineering Laboratory, TechMed Centre , University of Twente , P.O. Box 217, 7500 AE Enschede , The Netherlands.ORCID 0000-0001-6271-0049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Release of growth factors while simultaneously maintaining their full biological activity over a period of days to weeks is an important issue in controlled drug delivery and in tissue engineering. In addition, the selected strategy to immobilize growth factors largely determines their biological activity. Silica surfaces derivatized with glycidyloxy propyl trimethoxysilane and poly(glycidyl methacrylate) brushes yielded epoxide-functionalized surfaces onto which human bone morphogenetic protein-6 (hBMP-6) was immobilized giving stable secondary amine bonds. The biological activity of hBMP-6 was unleashed by hydrolysis of the surface siloxane and ester bonds. We demonstrate that this type of labile bonding strategy can be applied to biomaterial surfaces with relatively simple and biocompatible chemistry, such as siloxane, ester, and imine bonds. Our data indicates that the use of differential hydrolytically labile linkers is a versatile method for functionalization of biomaterials with a variety of growth factors providing control over their biological activity.

Indexed as

Biocompatible MaterialsBone Morphogenetic Protein 6HumansHydrolysisSilicon DioxideTissue EngineeringBiocompatible MaterialsBMP6 protein, humanBone Morphogenetic Protein 6Silicon Dioxide

Identifiers

PMID30005569
PMCPMC6143286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.